这是一篇来自已证抗体库的有关
人类 PRKD3的综述,是根据4篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PRKD3 抗体。
PRKD3 同义词: EPK2; PKC-NU; PKD3; PRKCN; nPKC-NU; serine/threonine-protein kinase D3; protein kinase C nu type; protein kinase EPK2
亚诺法生技股份有限公司
小鼠 单克隆(4G7) | | 亚诺法生技股份有限公司 PRKD3抗体(Abnova, H00023683-M01)被用于被用于免疫组化在人类样本上. Mol Cancer Ther (2015) ncbi |
赛信通(上海)生物试剂有限公司
兔 单克隆(D57E6) | | 赛信通(上海)生物试剂有限公司 PRKD3抗体(Cell Signaling, 5655)被用于被用于免疫印迹在人类样本上 (图 s2). Sci Rep (2016) ncbi |
兔 单克隆(D57E6) | | 赛信通(上海)生物试剂有限公司 PRKD3抗体(Cell Signaling, 5655)被用于被用于免疫印迹在人类样本上浓度为1:850. J Biol Chem (2015) ncbi |
兔 单克隆(D57E6) | | 赛信通(上海)生物试剂有限公司 PRKD3抗体(Cell Signaling, 5655)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2014) ncbi |
Xiong J, Zhou M, Wang Y, Chen L, Xu W, Wang Y,
et al. Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Sci Rep. 2016;6:34079
pubmed 出版商
Higa Nakamine S, Maeda N, Toku S, Yamamoto H. Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone. J Biol Chem. 2015;290:25974-85
pubmed 出版商
Borges S, Perez E, Thompson E, Radisky D, Geiger X, Storz P. Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101. Mol Cancer Ther. 2015;14:1306-16
pubmed 出版商
Wei N, Chu E, Wipf P, Schmitz J. Protein kinase d as a potential chemotherapeutic target for colorectal cancer. Mol Cancer Ther. 2014;13:1130-41
pubmed 出版商